Saby Charles, Collin Guillaume, Sinane Maha, Buache Emilie, Van Gulick Laurence, Saltel Frédéric, Maquoi Erik, Morjani Hamid
Unité BioSpecT, EA7506, SFR CAP-Santé, UFR de Pharmacie, Université de Reims Champagne-Ardenne, Reims, France.
INSERM, UMR1053, BaRITOn Bordeaux Research in Translational Oncology, Bordeaux, France.
Front Pharmacol. 2019 May 3;10:462. doi: 10.3389/fphar.2019.00462. eCollection 2019.
Type I collagen is the major adhesive component in breast interstitial stroma, which represents the first barrier against tumor cell invasion after basement-membrane degradation. Among cellular receptors, type I collagen is able to activate discoidin domain receptors DDR1 and DDR2. We have previously shown that in 3D collagen matrix, DDR1 plays a key role as it promotes cell growth suppression and apoptosis through the upregulation of the pro-apoptotic mediator BIK in noninvasive luminal-like breast carcinoma cells. We have also shown that MT1-MMP is able to rescue these cells and protect them against the effects induced by collagen/DDR1/BIK axis. Our data suggested that the protective effect of MT1-MMP might be mediated through the degradation of type I collagen and/or DDR1 cleavage. Decreased DDR1 expression has been associated with the epithelial to mesenchymal transition process in breast cancer, and its overexpression in aggressive basal-like breast cancer cells reduces their invasiveness in 3D cultures and . In the present work, we propose to study the role of MT1-MMP in the resistance against collagen-induced apoptosis in basal-like breast carcinoma MDA-MB-231 cells. We aimed to investigate whether MT1-MMP depletion is able to restore apoptosis mediated by collagen/DDR1/BIK axis and to verify if such depletion is able to restore full-length DDR1 expression and phosphorylation. ShRNA strategy against MT1-MMP mRNA was able to partially restore full length DDR1 expression and phosphorylation. This was accompanied by a decrease in cell growth and an upregulation of BIK expression. This suggested that MT1-MMP expression in basal-like breast carcinoma cells, in addition to a low basal level of DDR1 expression, protects these cells against collagen-induced apoptosis DDR1 cleavage. Since DDR1 was moderately expressed in MDA-MB-231 cells, we then investigated whether overexpression of DDR1 could be able to increase its ability to suppress cell growth and to induce apoptosis. Data showed that overexpression of DDR1 induced a decrease in cell growth and an increase in BIK expression, suggesting that moderate expression level of full length DDR1 in basal-like breast carcinoma provides them with a capacity to resist to collagen-induced cell growth suppression and apoptosis. Finally, the combined overexpression of DDR1 and depletion of MT1-MMP in MDA-MB-231 cells synergistically increased collagen-induced cell growth suppression and apoptosis to a level similar to that observed in luminal breast carcinoma. Taken together, our data suggest that during the acquisition of mesenchymal features, the low level of DDR1 expression should be considered as an important biomarker in the prognosis of basal-like breast carcinoma, conferring them a high rate of cell growth and resistance to BIK-mediated apoptosis induced by the stromal collagen.
I型胶原蛋白是乳腺间质基质中的主要黏附成分,是基底膜降解后阻止肿瘤细胞侵袭的第一道屏障。在细胞受体中,I型胶原蛋白能够激活盘状结构域受体DDR1和DDR2。我们之前已经表明,在三维胶原蛋白基质中,DDR1发挥着关键作用,因为它通过上调促凋亡介质BIK来促进非侵袭性管腔样乳腺癌细胞的生长抑制和凋亡。我们还表明,MT1-MMP能够拯救这些细胞,并保护它们免受胶原蛋白/DDR1/BIK轴诱导的影响。我们的数据表明,MT1-MMP的保护作用可能是通过I型胶原蛋白的降解和/或DDR1的裂解来介导的。DDR1表达的降低与乳腺癌的上皮-间质转化过程有关,而其在侵袭性基底样乳腺癌细胞中的过表达会降低它们在三维培养中的侵袭性。在本研究中,我们旨在研究MT1-MMP在基底样乳腺癌MDA-MB-231细胞抵抗胶原蛋白诱导的凋亡中的作用。我们的目的是研究MT1-MMP的缺失是否能够恢复由胶原蛋白/DDR1/BIK轴介导的凋亡,并验证这种缺失是否能够恢复全长DDR1的表达和磷酸化。针对MT1-MMP mRNA的shRNA策略能够部分恢复全长DDR1的表达和磷酸化。这伴随着细胞生长的减少和BIK表达的上调。这表明,在基底样乳腺癌细胞中,MT1-MMP的表达,除了DDR1表达的低基础水平外,还保护这些细胞免受胶原蛋白诱导的凋亡和DDR1裂解。由于DDR1在MDA-MB-231细胞中适度表达,我们随后研究了DDR1的过表达是否能够增加其抑制细胞生长和诱导凋亡的能力。数据表明,DDR1的过表达导致细胞生长减少和BIK表达增加,这表明基底样乳腺癌中全长DDR1的适度表达水平使它们具有抵抗胶原蛋白诱导的细胞生长抑制和凋亡的能力。最后,MDA-MB-231细胞中DDR1的过表达和MT1-MMP的缺失协同增加了胶原蛋白诱导的细胞生长抑制和凋亡,达到了类似于管腔型乳腺癌中观察到的水平。综上所述,我们的数据表明,在获得间质特征的过程中,DDR1的低表达水平应被视为基底样乳腺癌预后的一个重要生物标志物,赋予它们高细胞生长率和对基质胶原蛋白诱导的BIK介导的凋亡的抗性。